Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, COVID-19, Paraesthesia
Clinical narrative: Bell´s Palsy; Got Covid19 after receiving the two primary doses of the Moderna Covid 19 vaccine; Tingling sensation continued after receiving the second dose of the Moderna Covid19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got Covid19 after receiving the two primary doses of the Moderna Covid 19 vaccine), BELL'S PALSY (Bell´s Palsy) and PARAESTHESIA (Tingling sensation continued after receiving the second dose of the Moderna Covid19 vaccine) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PARAESTHESIA (Tingling sensation continued after receiving the second dose of the Moderna Covid19 vaccine). In December 2021, the patient experienced COVID-19 (Got Covid19 after receiving the two primary doses of the Moderna Covid 19 vaccine). On an unknown date, the patient experienced BELL'S PALSY (Bell´s Palsy). At the time of the report, COVID-19 (Got Covid19 after receiving the two primary doses of the Moderna Covid 19 vaccine), BELL'S PALSY (Bell´s Palsy) and PARAESTHESIA (Tingling sensation continued after receiving the second dose of the Moderna Covid19 vaccine) outcome was unknown.            Concomitant medications were not reported. No treatment information was provided by the reporter.  Company comment: This is a spontaneous case concerning a 46-year-old, female patient with relevant medical history of experiencing tingling sensation after the first dose of mRNA-1273 vaccine and with vaccine history of receiving 2 doses of mRNA-1273 vaccine with unknown dosage interval as primary doses, who experienced the unexpected non-serious AESI event of Covid-19, the unexpected non-serious event of paraesthesia (tingling sensation) in unspecified location and the expected non-serious event of Bell's palsy. The events Covid-19, paraesthesia (tingling sensation) in unspecified location and Bell's palsy exact occurrence unknown but stated that the events occurred after the second dose of mRNA-1273 vaccine administration. The events were described as, patient experienced tingling sensation after receiving first dose of mRNA-1273 vaccine and tingling sensation continued after receiving the second dose of mRNA-1273 vaccine. Patient experienced Covid-19 after receiving the two primary doses of mRNA-1273 vaccine and at the time of report the patient has Bell's palsy. No reported treatment information. No other information surrounding the events was reported. The outcome of the events was unknown. The unknown dosage interval between the primary doses of mRNA-1273 vaccine, the unknown onset latency of the event Covid-19 and the current Covid-19 pandemic remain confounders for the event Covid-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-531648 (Patient Link).   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerning a 46-year-old, female patient with relevant medical history of experiencing tingling sensation after the first dose of mRNA-1273 vaccine and with vaccine history of receiving 2 doses of mRNA-1273 vaccine with unknown dosage interval as primary doses, who experienced the unexpected non-serious AESI event of Covid-19, the unexpected non-serious event of paraesthesia (tingling sensation) in unspecified location and the expected non-serious event of Bell's palsy. The events Covid-19, paraesthesia (tingling sensation) in unspecified location and Bell's palsy exact occurrence unknown but stated that the events occurred after the second dose of mRNA-1273 vaccine administration. The events were described as, patient experienced tingling sensation after receiving first dose of mRNA-1273 vaccine and tingling sensation continued after receiving the second dose of mRNA-1273 vaccine. Patient experienced Covid-19 after receiving the two primary doses of mRNA-1273 vaccine and at the time of report the patient has Bell's palsy. No reported treatment information. No other information surrounding the events was reported. The outcome of the events was unknown. The unknown dosage interval between the primary doses of mRNA-1273 vaccine, the unknown onset latency of the event Covid-19 and the current Covid-19 pandemic remain confounders for the event Covid-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.